BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PYVOBJECT//NONSGML Version 1//EN
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:20260911T155852Z - 33869@eupv304
DTSTART;TZID=Europe/Brussels:20261128T083000
DTEND;TZID=Europe/Brussels:20261128T140000
CREATED:20260911T155852Z
DESCRIPTION:<a href="https://www.analis.com/event/belsaci-symposium-2026-28
 8/register">BelSACI SYMPOSIUM 2026</a>\nBelSACI SYMPOSIUM 2026 Organised b
 y the Belgian Society for Allergy and Clinical Immunology (BELSACI) Saturd
 ay\, 28 November 2026\, at The Faculty Club\, Leuven\, from 8:30 a.m. to 2
  p.m. The main topic will be ANAPHYLAXIS. THE PROGRAM TIME PROGRAMME 08:30
  – 8:55 Opening\, coffee and breakfast 08:55 – 9:00 Welcome and introd
 uction Prof Dr Antoine Froidure\, UCLouvain · BelSACI Chair PART I | Burd
 en and new concepts in anaphylaxis\, including economic aspects Moderators
 : Dr Xavier Van Der Brempt and Prof Dr Christine Breynaert · Category VI 
 requested 09:00 – 9:45 Old allergens\, new foods\, changing risks: the f
 uture of food anaphylaxis. Prof Clare Mills\, University of Surrey\, UK 09
 :45 – 10:05 ORAL ABSTRACTS · Four selected presentations (titles to be 
 announced) 10:10 – 10:40 Tryptase revisited – a paradigm change Dr Dri
 es Wets\, KU Leuven 10:40 – 11:35 Coffee break and snacks PART II | Upda
 te in anaphylaxis management Moderators: Prof Virginie Doyen and Dr Valér
 ie Pékus 11:35 – 11:55 ORAL ABSTRACTS · Four selected presentations (t
 itles to be announced) 12:00 – 12:30 New forms of epinephrine: the prese
 nt and the future of anaphylaxis management in children Dr Sarah De Schryv
 er\, AZ Sint-Lucas\, Ghent PART III | BelSACI General Assembly 12:30 – 1
 3:00 BelSACI General Assembly and election results 13:00 – 13:15 Final r
 emarks\, prizes and closing of the meeting Come to discover our new innova
 tive solutions in the field of allergy research: A Next-Generation Basophi
 l Activation Test (BAT) for research use only\, designed to more effective
 ly characterise food allergies without exposure to potentially harmful all
 ergens. Approximately 220 million people globally suffer from at least one
  food allergy. Most food allergies and treatment efficacies are currently 
 determined through a dated and rigorous Oral Food Challenge (OFC)\, which 
 exposes patients to gradual amounts of food to [...]
DTSTAMP:20260911T155852Z
LOCATION:Groot Begijnhof 14\, 3000 Leuven\, Belgium
SUMMARY:BelSACI SYMPOSIUM 2026
X-ALT-DESC;FMTTYPE=text/html:<a href="https://www.analis.com/event/belsaci-
 symposium-2026-288/register">BelSACI SYMPOSIUM 2026</a>\nBelSACI SYMPOSIUM
  2026 Organised by the Belgian Society for Allergy and Clinical Immunology
  (BELSACI) Saturday\, 28 November 2026\, at The Faculty Club\, Leuven\, fr
 om 8:30 a.m. to 2 p.m. The main topic will be ANAPHYLAXIS. THE PROGRAM TIM
 E PROGRAMME 08:30 – 8:55 Opening\, coffee and breakfast 08:55 – 9:00 W
 elcome and introduction Prof Dr Antoine Froidure\, UCLouvain · BelSACI Ch
 air PART I | Burden and new concepts in anaphylaxis\, including economic a
 spects Moderators: Dr Xavier Van Der Brempt and Prof Dr Christine Breynaer
 t · Category VI requested 09:00 – 9:45 Old allergens\, new foods\, chan
 ging risks: the future of food anaphylaxis. Prof Clare Mills\, University 
 of Surrey\, UK 09:45 – 10:05 ORAL ABSTRACTS · Four selected presentatio
 ns (titles to be announced) 10:10 – 10:40 Tryptase revisited – a parad
 igm change Dr Dries Wets\, KU Leuven 10:40 – 11:35 Coffee break and snac
 ks PART II | Update in anaphylaxis management Moderators: Prof Virginie Do
 yen and Dr Valérie Pékus 11:35 – 11:55 ORAL ABSTRACTS · Four selected
  presentations (titles to be announced) 12:00 – 12:30 New forms of epine
 phrine: the present and the future of anaphylaxis management in children D
 r Sarah De Schryver\, AZ Sint-Lucas\, Ghent PART III | BelSACI General Ass
 embly 12:30 – 13:00 BelSACI General Assembly and election results 13:00 
 – 13:15 Final remarks\, prizes and closing of the meeting Come to discov
 er our new innovative solutions in the field of allergy research: A Next-G
 eneration Basophil Activation Test (BAT) for research use only\, designed 
 to more effectively characterise food allergies without exposure to potent
 ially harmful allergens. Approximately 220 million people globally suffer 
 from at least one food allergy. Most food allergies and treatment efficaci
 es are currently determined through a dated and rigorous Oral Food Challen
 ge (OFC)\, which exposes patients to gradual amounts of food to [...]
END:VEVENT
END:VCALENDAR
